BBNX
Beta Bionics Inc.

202
Mkt Cap
$1.22B
Volume
281,605.00
52W High
$30.47
52W Low
$8.89
PE Ratio
-15.47
BBNX Fundamentals
Price
$28.48
Prev Close
$27.72
Open
$28.30
50D MA
$23.66
Beta
1.74
Avg. Volume
702,336.43
EPS (Annual)
-$1.26
P/B
4.14
Rev/Employee
$223,793.81
Loading...
Loading...
News
all
press releases
Insider Selling: Beta Bionics (NASDAQ:BBNX) Director Sells 1,406 Shares of Stock
Beta Bionics, Inc. (NASDAQ:BBNX - Get Free Report) Director Adam Lezack sold 1,406 shares of the firm's stock in a transaction that occurred on Friday, October 31st. The shares were sold at an...
MarketBeat·14d ago
News Placeholder
More News
News Placeholder
Beta Bionics, Inc. (BBNX) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Beta Bionics, Inc. (BBNX) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·23d ago
News Placeholder
Truist starts on diabetes device makers, sees glucose monitor, insulin pump growth
Investing.com -- Truist Securities launched coverage on four diabetes technology companies, saying there is a long-term growth potential for continuous glucose monitors (CGM) and insulin pumps amid rising adoption in both type 1 and type 2 diabetes patients.
investing.com·5mo ago
News Placeholder
Beta Bionics Stock Gains After Mixed Analyst Coverage; Wolfe Bullish, Goldman Neutral
Wolfe Research initiated coverage with an ‘Outperform’ rating and a $20 target, while Goldman Sachs started at ‘Neutral’ with a $16 target, citing balanced growth prospects and valuation.
Stocktwits·6mo ago
News Placeholder
Artificial Pancreas Maker Beta Bionics Just Started Trading. Should You Buy BBNX Stock After Its IPO?
This healthcare technology company is guiding for revenue growth of 150% for Q4.
barchart.com·10mo ago

Latest BBNX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.